Main Content

Press Release


ELEKTA’S NOMINATION COMMITTEE APPOINTED

PRESS RELEASE

Stockholm, May 28, 2004

In accordance with the decision at the Annual General Meeting on September 22, 2003, the Chairman of the Board of Directors in Elekta, Mr Akbar Seddigh, has today conducted a meeting with representatives for the company’s largest shareholders during the third quarter of fiscal year 2003/04. This group will together and under the leadership of the Chairman develop a proposal for members of the Board to be submitted to the Annual General Meeting for decision.

The shareholders and their representatives who will participate in the nomination process prior to Elekta’s Annual General Meeting on September 21, 2004, are:

Nordea SA, Léon Kirch
SEB Fonder, Björn Lind
Robur Fonder, Marianne Nilsson
Tredje AP-fonden, Pernilla Klein
Skandia Liv, Caroline af Ugglas
Laurent Leksell with family and company

As of April 30, 2004, these shareholders together represent over 44 percent of the votes in Elekta AB.

For further information, please contact:

Peter Ejemyr, Group VP Corporate Communications, Elekta AB (publ),
Phone: +46 733 611 000, e-mail: peter.ejemyr@elekta.com

Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient.

For additional information about Elekta, please visit www.elekta.com


This information was brought to you by Waymaker http://www.waymaker.net

The following files are available for download:


PDF Version